Different Criteria for the Definition of Insulin Resistance and ItsRelation with Dyslipidemia in Overweight and Obese Childrenand Adolescents|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Purpose: to compare cut off points corrected for age and gender (COOP) with fixed cut off points (FCOP) for fasting plasma insulin and Homeostatic model assessment-insulin resistance (HOMA-IR) for the diagnosis of IR in obese children and adolescents and their correlation with dyslipidemia.Methods: A multicenter, cross-sectional study including 383 subjects aged 7 to 18 years, evaluating fasting blood glucose, plasma insulin, and lipid profile. Subjects with high insulin levels and/or HOMA-IR were considered as having IR, based on two defining criteria: FCOP or CCOP. The frequency of metabolic abnormalities, the presence of IR, and the presence of dyslipidemia in relation to FCOP or CCOP were analyzed using Fisher and Mann-Whitney exact tests.Results: Using HOMA-IR, IR was diagnosed in 155 (40.5%) and 215 (56.1%) patients and, using fasting insulin, 150 (39.2%) and 221 (57.7%), respectively applying FCOP and CCOP. The use of CCOP resulted in lower insulin and HOMA-IR values than FCOP. Dyslipidemia was not related to FCOP or CCOP. Blood glucose remained within normal limits in all patients with IR. There was no difference in the frequency of IR identified by plasma insulin or HOMA-IR, both for FCOP and CCOP.Conclusion: The CCOP of plasma insulin or of HOMA-IR detected more cases of IR as compared to the FCOP, but were not associated with the frequency of dyslipidemia. As blood glucose has almost no fluctuation in this age group, even in the presence of IR, fasting plasma insulin detected the same cases of IR that would be detected by HOMA-IR.

번역하기

참고문헌 (Reference)

1 Nogueira-de-Almeida CA, "Ultrasonographic assessment of the common carotid intima-media complex in normal weight children and in overweight/obese children" 30 : 2016

2 DeFronzo RA. Lilly lecture, "The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM" 37 : 667-687, 1987

3 Madeira IR, "The role of metabolic syndrome components and adipokines in insulin resistance in prepubertal children" 24 : 289-295, 2011

4 Zimmet P, "The metabolic syndrome in children and adolescents-an IDF consensus report" 8 : 299-306, 2007

5 Pastucha D, "The incidence of metabolic syndrome in obese Czech children: the importance of early detection of insulin resistance using homeostatic indexes HOMA-IR and QUICKI" 62 : 277-283, 2013

6 Wallace TM, "The assessment of insulin resistance in man" 19 : 527-534, 2002

7 Garcia Cuartero B, "The HOMA and QUICKI indexes, and insulin and C-peptide levels in healthy children. Cut off points to identify metabolic syndrome in healthy children" 66 : 481-490, 2007

8 Salazar MR, "Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk" 8 : 109-116, 2011

9 de Onis M, "Preventing childhood overweight and obesity" 91 : 105-107, 2015

10 Sekokotla MA, "Prevalence of metabolic syndrome in adolescents living in Mthatha, South Africa" 13 : 131-137, 2017